Today: 15 June 2026
Browse Category

NYSE:HPE 9 July 2025 - 14 December 2025

Hewlett Packard Enterprise (HPE) Stock: What to Know Before the U.S. Market Open on Dec. 15, 2025

Hewlett Packard Enterprise (HPE) Stock: What to Know Before the U.S. Market Open on Dec. 15, 2025

Hewlett Packard Enterprise shares closed Friday at $23.87, down 2.73%, with trading volume well above average. The stock sits nearly 10% below its October high after a volatile response to Q4 results and FY2026 guidance. HPE reported strong networking growth but weaker server and hybrid cloud revenue. Investors remain split on near-term revenue risks versus improved FY26 earnings and cash flow outlook.
14 December 2025
·
Hewlett Packard Enterprise (HPE) Stock After Hours on Dec. 12, 2025: What Happened, Latest News & Forecasts, and What to Watch Before the Next Market Open

Hewlett Packard Enterprise (HPE) Stock After Hours on Dec. 12, 2025: What Happened, Latest News & Forecasts, and What to Watch Before the Next Market Open

Hewlett Packard Enterprise shares closed Friday at $23.87, down 2.73%, with volume near 46 million, well above average. After hours, the stock was flat at $23.87. The S&P 500 and Dow also fell as concerns over AI infrastructure spending weighed on tech stocks. HPE’s recent quarterly report showed revenue up 14% to $9.7 billion, with strong networking growth but declines in servers and hybrid cloud.
13 December 2025
··
Hewlett Packard Enterprise (HPE) Stock Today: Argus Lifts Target to $30 as AI Networking, Q4 Earnings and Insider Trades Move the Story

Hewlett Packard Enterprise (HPE) Stock Today: Argus Lifts Target to $30 as AI Networking, Q4 Earnings and Insider Trades Move the Story

Hewlett Packard Enterprise shares rose over 1% to $25.04 Wednesday after Q4 earnings beat EPS forecasts but missed slightly on revenue. The company reported $9.7 billion in revenue, $0.62 non-GAAP EPS, and strong AI-driven growth at its Discover Barcelona event. HPE’s market cap stands at $32.6 billion, with the stock up 16% year-to-date but trailing the Nasdaq’s gains.
10 December 2025
···
Hewlett Packard Enterprise (HPE) Stock Today: Q4 2025 Earnings, AI Factories and 2026 Outlook for Investors

Hewlett Packard Enterprise (HPE) Stock Today: Q4 2025 Earnings, AI Factories and 2026 Outlook for Investors

Hewlett Packard Enterprise shares traded near $24 on December 8, 2025, after reporting record Q4 revenue of $9.7 billion, up 14% year over year. The stock fell over 8% post-earnings due to a modest revenue miss and volatility in server and hybrid cloud segments. Non-GAAP EPS rose to $0.62, while GAAP earnings dropped sharply. Wall Street consensus rates HPE between "Hold" and "Moderate Buy."
8 December 2025
··
Stock Market Today: Futures Edge Higher as September PCE Inflation Data Keeps Fed Rate‑Cut Bets Alive

Stock Market Today: Futures Edge Higher as September PCE Inflation Data Keeps Fed Rate‑Cut Bets Alive

U.S. stock futures rose Friday after the delayed September PCE inflation report showed annual headline inflation at 2.8% and core at 2.9%, both in line with forecasts. Futures markets still price an 85–90% chance of a Fed rate cut next week. S&P 500 futures gained 0.2%, Nasdaq 100 futures 0.35%. Global shares headed for a second week of gains.
5 December 2025
·····
Hewlett Packard Enterprise (HPE) Stock: Q4 2025 Earnings, AI Server Slowdown and Analyst Forecasts as of December 5, 2025

Hewlett Packard Enterprise (HPE) Stock: Q4 2025 Earnings, AI Server Slowdown and Analyst Forecasts as of December 5, 2025

Hewlett Packard Enterprise reported record Q4 2025 revenue of $9.7 billion, up 14% year-over-year, but missed Wall Street estimates due to delayed AI server shipments. Shares rose 2.9% on December 4, then dropped nearly 9% after hours before rebounding. GAAP EPS fell to $0.11 on acquisition charges, while non-GAAP EPS beat guidance at $0.62. The company declared a $0.1425 quarterly dividend, payable January 16.
5 December 2025
··
US Stock Market Today, December 4, 2025: Wall Street Ends Mixed Near Record Highs as Fed Rate‑Cut Bets Build

US Stock Market Today, December 4, 2025: Wall Street Ends Mixed Near Record Highs as Fed Rate‑Cut Bets Build

The S&P 500 rose 0.1% to 6,857.12 and the Nasdaq gained 0.2% to 23,505.14 on Thursday, while the Dow slipped 0.07% to 47,850.94. The Russell 2000 jumped 0.8% to a record 2,531 as investors bet on a Federal Reserve rate cut next week. Jobless claims fell to their lowest since 2022, but announced layoffs for 2025 hit a post-pandemic high.
4 December 2025
···········
HPE Stock Falls as Weak 2026 Revenue Forecast Overshadows Q4 2025 Earnings Beat

HPE Stock Falls as Weak 2026 Revenue Forecast Overshadows Q4 2025 Earnings Beat

Hewlett Packard Enterprise reported Q4 2025 revenue of $9.7 billion, missing Wall Street estimates, while non-GAAP EPS of $0.62 beat forecasts. The company issued a weaker sales outlook for early 2026, sending shares down 4–5% after hours. Server revenue fell 5% amid delayed deals and tough AI competition. Annualized revenue run-rate rose 63% to $3.2 billion.
4 December 2025
···
Nvidia Stock After the Bell: NVDA Near $180 as $2 Billion Synopsys Stake, HPE Deal and AI Bubble Fears Collide – December 1, 2025

Nvidia Stock After the Bell: NVDA Near $180 as $2 Billion Synopsys Stake, HPE Deal and AI Bubble Fears Collide – December 1, 2025

Nvidia shares closed at $179.98 Monday, up 1.7%, defying declines in major U.S. indexes. The gain followed news of a $2 billion equity stake in Synopsys and expanded AI partnerships. After-hours trading saw Nvidia edge to $180.14. Volume reached about 145 million shares, near its daily average.
1 December 2025
·····
AI Hype vs Reality: HPE Stock’s Wild October Ride and What’s Next for Investors

HPE Stock Today: Hewlett Packard Enterprise Dips as $1.8 Billion Autonomy Claim, China Stake Sale and Margin Fears Collide (Nov. 18, 2025)

Hewlett Packard Enterprise shares fell nearly 1% to about $21 midday Tuesday after the company filed a $1.8 billion legal claim tied to its Autonomy acquisition and sold a $714 million stake in its Chinese joint venture H3C. HPE stock is down 8% over the past week and trades about 20% below its 52-week high, with broader market declines adding pressure.
18 November 2025
·
AI Hype vs Reality: HPE Stock’s Wild October Ride and What’s Next for Investors

AI Hype vs Reality: HPE Stock’s Wild October Ride and What’s Next for Investors

Hewlett Packard Enterprise stock fell sharply after issuing cautious 2026 guidance on Oct. 15, projecting 5–10% revenue growth, well below Wall Street’s expectations. Shares dropped over 8% before rebounding to around $23–$24. HPE announced a 10% dividend hike and a $3 billion buyback. The company recently closed its $14 billion Juniper Networks acquisition.
22 October 2025
···
HPE Stock Soars and Dips: Inside Hewlett Packard Enterprise’s Wild October Ride

HPE Stock Soars and Dips: Inside Hewlett Packard Enterprise’s Wild October Ride

Hewlett Packard Enterprise shares fell 5–7% after hours on Oct. 15 following cautious FY2026 guidance, despite a recent 52-week high of $26.44 and a 16% year-to-date gain. The company announced a 10% dividend increase and $3 billion in new buybacks at its analyst meeting. Q3 revenue rose 19% to $9.14 billion, but EPS missed forecasts. HPE’s AI tech was recently licensed by Nokia for telecom automation.
16 October 2025
·
High-Performance Computing Highlights (June–July 2025): Exascale Era, HPC-AI Convergence, and Global Supercomputing Advances

High-Performance Computing Highlights (June–July 2025): Exascale Era, HPC-AI Convergence, and Global Supercomputing Advances

El Capitan at Lawrence Livermore National Lab topped the June 2025 TOP500 list with 1.742 exaFLOPS on HPL. Frontier at Oak Ridge ranked second with 1.353 exaFLOPS, followed by Aurora at Argonne with 1.012 exaFLOPS. JUPITER Booster debuted at #4, and Microsoft Azure’s Eagle placed fifth. Europe had three systems in the Top 10.
9 July 2025
·····
1 2 3

Stock Market Today

  • Jazz Pharmaceuticals Shares Fall 2% After Zepzelca Lung Cancer Study Misses Primary Endpoint
    June 15, 2026, 1:53 PM EDT. Shares of Jazz Pharmaceuticals fell 2.4% after its phase III LAGOON study showed lung cancer drug Zepzelca (lurbinectedin) failed the primary endpoint of overall survival in relapsed small cell lung cancer patients. Median survival was 8.7 months for Zepzelca monotherapy and 10.9 months for combination therapy versus 10.7 months in controls, showing no meaningful benefit. The study was critical for converting accelerated approval granted in 2020 to full approval. Jazz plans to discuss results with the FDA but expects no impact on its 2026 financial outlook. Strong growth in first-line maintenance use of Zepzelca, approved in combination with Tecentriq, helped Jazz post $101 million in first-quarter 2026 sales, up 60% year-over-year.

Latest articles

Pattern Group Slides as Knox Lane Affiliate Plans 8 Million Share Sale

Pattern Group Slides as Knox Lane Affiliate Plans 8 Million Share Sale

15 June 2026
Pattern Group shares plunged 11% to $18.61 after a Knox Lane-affiliated pre-IPO holder launched a secondary offering of 8 million Series A shares, with an option for 1.2 million more; Pattern will not receive proceeds, and the increased share supply weighed on investor sentiment.
Nasdaq Tech Stocks Climb, QQQ Gains After U.S.-Iran Deal Hopes

Nasdaq Tech Stocks Climb, QQQ Gains After U.S.-Iran Deal Hopes

15 June 2026
Invesco QQQ Trust surged 3.1% to $743.54 as a preliminary U.S.-Iran deal sent oil prices down 5%, easing inflation and rate-hike fears, and fueling a tech-led rally with chip stocks like Micron up 9.2% and Nvidia up 3%, while leveraged fund TQQQ soared 9.2%.
Accenture drops on Morgan Stanley downgrade tied to AI spending

Accenture drops on Morgan Stanley downgrade tied to AI spending

15 June 2026
Morgan Stanley downgraded Accenture to Equal Weight and slashed its price target to $177 from $240, citing weaker-than-expected IT services budget growth and AI spending pressure; Accenture shares recently traded near $169, down about 0.8%, after falling 43.9% over the past year as investors await clarity on AI-driven demand ahead of the June 18 earnings call.
Go toTop